Raw Data Library
About
Aims and ScopeAdvisory Board Members
More
Who We Are?
User Guide
Green Science
​
​
EN
Kurumsal BaşvuruSign inGet started
​
​

About
Aims and ScopeAdvisory Board Members
More
Who We Are?
User GuideGreen Science

Language

Kurumsal Başvuru

Sign inGet started
RDL logo

Verified research datasets. Instant access. Built for collaboration.

Navigation

About

Aims and Scope

Advisory Board Members

More

Who We Are?

Contact

Add Raw Data

User Guide

Legal

Privacy Policy

Terms of Service

Support

Got an issue? Email us directly.

Email: info@rawdatalibrary.netOpen Mail App
​
​

© 2026 Raw Data Library. All rights reserved.
PrivacyTermsContact
  1. Raw Data Library
  2. /
  3. Publications
  4. /
  5. Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study

Verified authors • Institutional access • DOI aware
50,000+ researchers120,000+ datasets90% satisfaction
Preprint
English
2021

Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study

0 Datasets

0 Files

English
2021
Wellcome Open Research
Vol 6
DOI: 10.12688/wellcomeopenres.16880.2

Get instant academic access to this publication’s datasets.

Create free accountHow it works

Frequently asked questions

Is access really free for academics and students?

Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.

How is my data protected?

Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.

Can I request additional materials?

Yes, message the author after sign-up to request supplementary files or replication code.

Advance your research today

Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.

Get free academic accessLearn more
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaboration
Access Research Data

Join our academic network to download verified datasets and collaborate with researchers worldwide.

Get Free Access
Institutional SSO
Secure
This PDF is not available in different languages.
No localized PDFs are currently available.
Sir Nicholas White
Sir Nicholas White

University Of Cambridge

Verified
Carlo Perrone
William HK Schilling
James J. Callery
+19 more

Abstract

Background: The COPCOV study (chloroquine/ hydroxychloroquine prevention of coronavirus disease), which started recruitment in April 2020, is a multi-country double-blind, randomised, placebo-controlled trial which is being conducted in healthcare facilities involved in COVID-19 case management. COPCOV aims to recruit healthcare workers and other staff employed in facilities managing people with proven or suspected COVID-19. Methods: We conducted a series of engagement sessions, each involving a short presentation of the study, a section where attendees were asked to express if they would be interested in participating in such a study and which information they would need to change their view and an open Q&A section. Answers were transcribed and coded into themes by two independent investigators. Themes were derived from the data. The aims were to assess the feasibility of the study at the respective sites, to identify context-specific ethical issues, to understand concerns potential participants might have, to fine tune research procedures and to refine COPCOV information materials. They complemented other site-specific engagement, communication and public relation activities such as press releases and websites. Results: From 16th March 2020 to 20th January 2021, 12 engagement sessions were conducted in Thailand, Laos, Vietnam, Nepal and the UK involving 213 attendees in total. The sessions were designed to encourage potential participants and research professionals not directly involved in the project to interact with those who planned the study and those conducting it. Many attendees were keen to join the study while others had concerns. Questions raised revolved around the social value and study rationale; safety of trial medications and risk-benefit balance; study design and commitments. Conclusions: These sessions helped us refine information materials, identify misunderstandings about the study as well as complement site feasibility assessments. Our experience strongly supports the use of participatory practices prior to conducting clinical trials.

How to cite this publication

Carlo Perrone, William HK Schilling, James J. Callery, Elizabeth A. Ashley, Mary Chambers, Hannah Chase, Piyush Dahal, Nipaphan Kanthawang, Supalert Nedsuwan, Borimas Hanboonkunupakarn, Daranee Intralawan, Abhilasha Karkey, Mayfong Mayxay, Vimalay Souvong, Hien Tran Minh, Summita Udas Shakya, Sanjib Kumar Sharma, Surendra Uranw, Souphaphone Vannachione, Charles J. Woodrow, Sir Nicholas White, Phaik Yeong Cheah (2021). Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study. Wellcome Open Research, 6, pp. 216-216, DOI: 10.12688/wellcomeopenres.16880.2.

Related publications

Why join Raw Data Library?

Quality

Datasets shared by verified academics with rich metadata and previews.

Control

Authors choose access levels; downloads are logged for transparency.

Free for Academia

Students and faculty get instant access after verification.

Publication Details

Type

Preprint

Year

2021

Authors

22

Datasets

0

Total Files

0

Language

English

Journal

Wellcome Open Research

DOI

10.12688/wellcomeopenres.16880.2

Join Research Community

Access datasets from 50,000+ researchers worldwide with institutional verification.

Get Free Access